Concepedia

Tavaborole Therapy

Tavaborole Therapy is a pharmacotherapeutic intervention characterized by the topical application of tavaborole, a benzoxaborole antifungal agent, specifically indicated for the treatment of onychomycosis caused by Trichophyton rubrum.

20

Publications

725

Citations

76

Authors

37

Institutions

Publications per year

2017–2026

6

Parents

Publications

20

Efficacy and safety of tavaborole topical solution, 5%, a novel boron-based antifungal agent, for the treatment of toenail onychomycosis: Results from 2 randomized phase-III studies

Boni E. Elewski, Raza Aly, Sheryl L. Baldwin et al. · Journal of the American Academy of Dermatology · 2015 · 161 citations · Full text

, , +17

Tavaborole: First Global Approval

Anthony Markham · Drugs · 2014 · 72 citations

, , +2

An upcoming drug for onychomycosis: Tavaborole

Neha Sharma, Dhruva Sharma · Journal of Pharmacology and Pharmacotherapeutics · 2015 · 64 citations · Full text

, , +17

Tavaborole for the treatment of onychomycosis

Boni E. Elewski, Antonellá Tosti · Expert Opinion on Pharmacotherapy · 2014 · 51 citations

, , +17

An assessment of the genetic toxicology of novel boron‐containing therapeutic agents

Vic Ciaravino, Jacob J. Plattner, Sanjay Chanda · Environmental and Molecular Mutagenesis · 2013 · 50 citations

, , +11

1–5 of 20

Authors

76

  1. LT
    Lee T. Zane

    University of California, San Francisco, United States

    6 publications · 264 citations

    6

    h-index

  2. SC
    Sanjay Chanda

    University of Louisiana at Monroe, United States

    5 publications · 138 citations

    5

    h-index

  3. DC
    Dina Coronado

    MPI Research (United States), United States

    4 publications · 88 citations

    4

    h-index

  4. PR
    Phoebe Rich

    Oregon Health & Science University, United States

    3 publications · 203 citations

    3

    h-index

  5. RP
    Richard Pollak

    Clinical Trials of Texas, United States

    2 publications · 178 citations

    2

    h-index

1–5 of 76

Institutions

37

  1. University of Toronto

    Toronto, Canada

    3 h-index

    3 publications

    86 citations

  2. Kaken Pharmaceutical (Japan)

    Tokyo, Japan

    2 h-index

    7 publications

    123 citations

  3. Mediprobe Research (Canada)

    London, Canada

    2 h-index

    3 publications

    56 citations

  4. University of Alabama at Birmingham

    Birmingham, United States

    2 h-index

    2 publications

    212 citations

  5. MPI Research (United States)

    Mattawan, United States

    1 h-index

    1 publications

    20 citations

  6. Third Xiangya Hospital

    Changsha, China

    1 h-index

    6 publications

    114 citations

  7. Oregon Dermatology & Research Center

    Portland, United States

    1 h-index

    1 publications

    18 citations

  8. Radboud University Medical Center

    Nijmegen, The Netherlands

    1 h-index

    1 publications

    26 citations

1–8 of 37

Venues

  1. PubMed

    Repository · 6 publications · 158 citations

    6

    h-index

  2. Journal of Fungi

    JoF · 2 publications · 36 citations

    2

    h-index

  3. Antimicrobial Agents and Chemotherapy

    AAC · 1 publications · 26 citations

    1

    h-index

  4. Journal of Materials Chemistry B

    1 publications · 18 citations

    1

    h-index

  5. Hospital Pharmacy

    1 publications · 13 citations

    1

    h-index

1–5